Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.

Although cytotoxic chemotherapy is widely used in advanced breast cancer, there are no powerful predictors for the therapy response. Because topoisomerase IIalpha (Topo IIalpha) is the molecular target for the anthracycline class of anti-cancer drugs, we compared the immunocytochemical assay of Topo...

Descripción completa

Detalles Bibliográficos
Autores principales: Järvinen, T. A., Holli, K., Kuukasjärvi, T., Isola, J. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150425/
https://www.ncbi.nlm.nih.gov/pubmed/9649144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150425/
https://www.ncbi.nlm.nih.gov/pubmed/9649144

Ejemplares similares